Easier, Noninvasive Diagnosis of Neurological Disorders
More companies have begun offering neurofilament light chain blood tests as a cost-effective alternative to conventional methods.
More companies have begun offering neurofilament light chain blood tests as a cost-effective alternative to conventional methods.
A new test targeting changes in serum proteins can detect breast cancer up to two years before the condition would normally be diagnosed.
Recent study shows the new test can identify a widespread and dangerous class of synthetic cannabinoids called BZO-CHMOXIZID.
Based on validation study data, the test offers 90 percent accuracy and is unaffected by the emergence of new COVID-19 variants.
Recent study suggests a new test may help doctors detect Lyme disease during the early stages when treatment is likely to be more effective.